Harel Insurance Investments & Financial Services’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-7,991
Closed -$237K 699
2023
Q1
$237K Buy
7,991
+5,240
+190% +$173K ﹤0.01% 313
2022
Q4
$85K Sell
2,751
-38
-1% -$1.14K ﹤0.01% 392
2022
Q3
$67K Sell
2,789
-29,536
-91% -$974K ﹤0.01% 461
2022
Q2
$1.03M Buy
+32,325
New +$1.19M 0.02% 181
2021
Q2
Sell
-24,000
Closed -$2.24M 779
2021
Q1
$2.24M Buy
24,000
+20,416
+570% +$543K 0.04% 226
2020
Q4
$286K Buy
+3,584
New +$85.3K 0.01% 444

Other funds holding CC

Harel Insurance Investments & Financial Services's CC Position: Q2 2023 in Review

Harel Insurance Investments & Financial Services sold out of Chemours (CC) in Q2 2023, closing a stake of 7,991 shares — an estimated $237K sold.

Harel Insurance Investments & Financial Services first reported a position in CC in Q4 2020 and held it in 6 quarters. The position peaked at $2.24M in Q1 2021. 476 funds tracked by Wall St. Rank hold CC as of Q2 2023.

  • Harel Insurance Investments & Financial Services reported no remaining Chemours position as of Q2 2023 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 7,991 Chemours shares in Q2 2023, an estimated $237K.
  • Harel Insurance Investments & Financial Services first reported a position in Chemours in Q4 2020 and held it in 6 quarters.
  • Harel Insurance Investments & Financial Services's Chemours position peaked at $2.24M in Q1 2021.
  • 476 funds tracked by Wall St. Rank held Chemours as of Q2 2023.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2023, filed 17 Jul 2023.